Developing new drugs is not for the faint-hearted. “It’s a pretty perilous journey,” says Paul Nioi, vice-president of discovery and translational research at Alnylam Pharmaceuticals. “It’s expensive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback